feed,title,long_url,short_url
Benzinga,Avidity Biosciences Shares Gain On Encouraging Data From Early-Stage Myotonic Dystrophy Trial,https://benzinga.com/general/biotech/22/12/30075552/avidity-biosciences-shares-gain-on-encouraging-data-from-early-stage-myotonic-dystrophy-trial,https://da.gd/4UiLi1
